174 related articles for article (PubMed ID: 35027740)
1. Multi-ancestry fine mapping implicates OAS1 splicing in risk of severe COVID-19.
Huffman JE; Butler-Laporte G; Khan A; Pairo-Castineira E; Drivas TG; Peloso GM; Nakanishi T; ; Ganna A; Verma A; Baillie JK; Kiryluk K; Richards JB; Zeberg H
Nat Genet; 2022 Feb; 54(2):125-127. PubMed ID: 35027740
[TBL] [Abstract][Full Text] [Related]
2. A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity.
Zhou S; Butler-Laporte G; Nakanishi T; Morrison DR; Afilalo J; Afilalo M; Laurent L; Pietzner M; Kerrison N; Zhao K; Brunet-Ratnasingham E; Henry D; Kimchi N; Afrasiabi Z; Rezk N; Bouab M; Petitjean L; Guzman C; Xue X; Tselios C; Vulesevic B; Adeleye O; Abdullah T; Almamlouk N; Chen Y; Chassé M; Durand M; Paterson C; Normark J; Frithiof R; Lipcsey M; Hultström M; Greenwood CMT; Zeberg H; Langenberg C; Thysell E; Pollak M; Mooser V; Forgetta V; Kaufmann DE; Richards JB
Nat Med; 2021 Apr; 27(4):659-667. PubMed ID: 33633408
[TBL] [Abstract][Full Text] [Related]
3. Reassessment of the type I diabetes association of the OAS1 locus.
Qu HQ; Polychronakos C;
Genes Immun; 2009 Dec; 10 Suppl 1(Suppl 1):S69-73. PubMed ID: 19956105
[TBL] [Abstract][Full Text] [Related]
4. Type 1 diabetes and the OAS gene cluster: association with splicing polymorphism or haplotype?
Tessier MC; Qu HQ; Fréchette R; Bacot F; Grabs R; Taback SP; Lawson ML; Kirsch SE; Hudson TJ; Polychronakos C
J Med Genet; 2006 Feb; 43(2):129-32. PubMed ID: 16014697
[TBL] [Abstract][Full Text] [Related]
5. A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene.
Magusali N; Graham AC; Piers TM; Panichnantakul P; Yaman U; Shoai M; Reynolds RH; Botia JA; Brookes KJ; Guetta-Baranes T; Bellou E; Bayram S; Sokolova D; Ryten M; Sala Frigerio C; Escott-Price V; Morgan K; Pocock JM; Hardy J; Salih DA
Brain; 2021 Dec; 144(12):3727-3741. PubMed ID: 34619763
[TBL] [Abstract][Full Text] [Related]
6. Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and African ancestries.
Banday AR; Stanifer ML; Florez-Vargas O; Onabajo OO; Papenberg BW; Zahoor MA; Mirabello L; Ring TJ; Lee CH; Albert PS; Andreakos E; Arons E; Barsh G; Biesecker LG; Boyle DL; Brahier MS; Burnett-Hartman A; Carrington M; Chang E; Choe PG; Chisholm RL; Colli LM; Dalgard CL; Dude CM; Edberg J; Erdmann N; Feigelson HS; Fonseca BA; Firestein GS; Gehring AJ; Guo C; Ho M; Holland S; Hutchinson AA; Im H; Irby L; Ison MG; Joseph NT; Kim HB; Kreitman RJ; Korf BR; Lipkin SM; Mahgoub SM; Mohammed I; Paschoalini GL; Pacheco JA; Peluso MJ; Rader DJ; Redden DT; Ritchie MD; Rosenblum B; Ross ME; Anna HPS; Savage SA; Sharma S; Siouti E; Smith AK; Triantafyllia V; Vargas JM; Vargas JD; Verma A; Vij V; Wesemann DR; Yeager M; Yu X; Zhang Y; Boulant S; Chanock SJ; Feld JJ; Prokunina-Olsson L
Nat Genet; 2022 Aug; 54(8):1103-1116. PubMed ID: 35835913
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of the protective OAS1 rs10774671-G allele against severe COVID-19 in Moroccans: implications for a North African Neanderthal connection.
Yousfi FZE; Haroun AE; Nebhani C; Belayachi J; Askander O; Fahime EE; Fares H; Ennibi K; Abouqal R; Razine R; Bouhouche A
Arch Virol; 2024 Apr; 169(5):109. PubMed ID: 38658463
[TBL] [Abstract][Full Text] [Related]
8. Single nucleotide variants in the
Chávez-Vélez E; Álvarez-Nava F; Torres-Vinueza A; Balarezo-Díaz T; Pilataxi K; Acosta-López C; Peña IZ; Narváez K
Front Cell Infect Microbiol; 2024; 14():1322882. PubMed ID: 38694517
[TBL] [Abstract][Full Text] [Related]
9. Global genetic variation at OAS1 provides evidence of archaic admixture in Melanesian populations.
Mendez FL; Watkins JC; Hammer MF
Mol Biol Evol; 2012 Jun; 29(6):1513-20. PubMed ID: 22319157
[TBL] [Abstract][Full Text] [Related]
10. A prenylated dsRNA sensor protects against severe COVID-19.
Wickenhagen A; Sugrue E; Lytras S; Kuchi S; Noerenberg M; Turnbull ML; Loney C; Herder V; Allan J; Jarmson I; Cameron-Ruiz N; Varjak M; Pinto RM; Lee JY; Iselin L; Palmalux N; Stewart DG; Swingler S; Greenwood EJD; Crozier TWM; Gu Q; Davies EL; Clohisey S; Wang B; Trindade Maranhão Costa F; Freire Santana M; de Lima Ferreira LC; Murphy L; Fawkes A; Meynert A; Grimes G; ; Da Silva Filho JL; Marti M; Hughes J; Stanton RJ; Wang ECY; Ho A; Davis I; Jarrett RF; Castello A; Robertson DL; Semple MG; Openshaw PJM; Palmarini M; Lehner PJ; Baillie JK; Rihn SJ; Wilson SJ
Science; 2021 Oct; 374(6567):eabj3624. PubMed ID: 34581622
[TBL] [Abstract][Full Text] [Related]
11. OAS1 gene, Spike protein variants and persistent COVID-19-related anosmia: may the olfactory disfunction be a harbinger of future neurodegenerative disease?
Di Stadio A; Bernitsas E; Ralli M; Severini C; Brenner MJ; Angelini C
Eur Rev Med Pharmacol Sci; 2022 Jan; 26(2):347-349. PubMed ID: 35113409
[No Abstract] [Full Text] [Related]
12. Alternative splicing of
Huffman J; Butler-Laporte G; Khan A; Drivas TG; Peloso GM; Nakanishi T; Verma A; Kiryluk K; Richards JB; Zeberg H
medRxiv; 2021 Mar; ():. PubMed ID: 33791713
[TBL] [Abstract][Full Text] [Related]
13. Long-term balancing selection at the antiviral gene OAS1 in Central African chimpanzees.
Ferguson W; Dvora S; Fikes RW; Stone AC; Boissinot S
Mol Biol Evol; 2012 Apr; 29(4):1093-103. PubMed ID: 22104212
[TBL] [Abstract][Full Text] [Related]
14. Adaptively introgressed Neandertal haplotype at the OAS locus functionally impacts innate immune responses in humans.
Sams AJ; Dumaine A; Nédélec Y; Yotova V; Alfieri C; Tanner JE; Messer PW; Barreiro LB
Genome Biol; 2016 Nov; 17(1):246. PubMed ID: 27899133
[TBL] [Abstract][Full Text] [Related]
15. Identification of a new susceptibility variant for multiple sclerosis in OAS1 by population genetics analysis.
Cagliani R; Fumagalli M; Guerini FR; Riva S; Galimberti D; Comi GP; Agliardi C; Scarpini E; Pozzoli U; Forni D; Caputo D; Asselta R; Biasin M; Paraboschi EM; Bresolin N; Clerici M; Sironi M
Hum Genet; 2012 Jan; 131(1):87-97. PubMed ID: 21735172
[TBL] [Abstract][Full Text] [Related]
16. OAS1 gene haplotype confers susceptibility to multiple sclerosis.
Fedetz M; Matesanz F; Caro-Maldonado A; Fernandez O; Tamayo JA; Guerrero M; Delgado C; López-Guerrero JA; Alcina A
Tissue Antigens; 2006 Nov; 68(5):446-9. PubMed ID: 17092260
[TBL] [Abstract][Full Text] [Related]
17. Evaluate the relationship between polymorphisms of OAS1 gene and susceptibility to chronic hepatitis C with high resolution melting analysis.
Zhao Y; Kang H; Ji Y; Chen X
Clin Exp Med; 2013 Aug; 13(3):171-6. PubMed ID: 22710942
[TBL] [Abstract][Full Text] [Related]
18. Host genetic variants associated with COVID-19 reconsidered in a Slovak cohort.
Skerenova M; Cibulka M; Dankova Z; Holubekova V; Kolkova Z; Lucansky V; Dvorska D; Kapinova A; Krivosova M; Petras M; Baranovicova E; Baranova I; Novakova E; Liptak P; Banovcin P; Bobcakova A; Rosolanka R; Janickova M; Stanclova A; Gaspar L; Caprnda M; Prosecky R; Labudova M; Gabbasov Z; Rodrigo L; Kruzliak P; Lasabova Z; Matakova T; Halasova E
Adv Med Sci; 2024 Mar; 69(1):198-207. PubMed ID: 38555007
[TBL] [Abstract][Full Text] [Related]
19. OAS1 splice site polymorphism controlling antiviral enzyme activity influences susceptibility to type 1 diabetes.
Field LL; Bonnevie-Nielsen V; Pociot F; Lu S; Nielsen TB; Beck-Nielsen H
Diabetes; 2005 May; 54(5):1588-91. PubMed ID: 15855350
[TBL] [Abstract][Full Text] [Related]
20. The human 2',5'-oligoadenylate synthetase-like gene (OASL) encoding the interferon-induced 56-kDa protein maps to chromosome 12q24.2 in the proximity of the 2',5'-OAS locus.
Hovnanian A; Rebouillat D; Levy ER; Mattei MG; Hovanessian AG
Genomics; 1999 Mar; 56(3):362-3. PubMed ID: 10087211
[No Abstract] [Full Text] [Related]
[Next] [New Search]
